NZSE:FPH
NZSE:FPHMedical Equipment

Upgraded Earnings Guidance And Dividend Lift Could Be A Game Changer For Fisher & Paykel Healthcare (NZSE:FPH)

Fisher & Paykel Healthcare has already reported half-year 2025 results showing sales of NZ$1,088.5 million and net income of NZ$213.0 million, alongside higher basic earnings per share and an increased interim dividend. The company also raised its full-year revenue and net profit guidance, signaling management confidence that recent operational momentum can continue. Next, we’ll explore how the upgraded full-year earnings guidance may influence Fisher & Paykel Healthcare’s existing...
NZSE:RAK
NZSE:RAKElectronic

Rakon (NZSE:RAK) Swings to Net Profit in H1 2026, Reinforcing Bullish Turnaround Narratives

Rakon (NZSE:RAK) just posted its H1 2026 results, reporting revenue of 62.004 million NZD and basic EPS of 0.0196 NZD. Looking back, the company has seen revenue go from 41.657 million NZD in H1 2025 to 66.756 million NZD in H2 2024 before reaching the latest figure. EPS moved from -0.046 NZD up to 0.018276 NZD, then to the current 0.0196 NZD. With these numbers out, it is clear margin performance continues to shape investor discussions around the business. See our full analysis for...
NZSE:RYM
NZSE:RYMHealthcare

Ryman Healthcare (NZSE:RYM) Net Loss Deepens to $564M, Testing Turnaround Narratives

Ryman Healthcare (NZSE:RYM) has just reported H1 2026 financial results, posting total revenue of $806.7 million NZD and basic EPS of -0.64 NZD for the trailing twelve months. Historically, the company has seen revenue climb from $355.2 million NZD in H2 2024 to $394.0 million NZD by H2 2025. Basic EPS over recent halves ranged from -0.72 NZD to 0.14 NZD. Margins continue to face pressure as profitability remains elusive, making this an essential set of numbers for investors to digest. See...
NZSE:SPG
NZSE:SPGREITs

Stride Property Group (NZSE:SPG) Margins Surge to 33.6%, Challenging Bearish Profitability Narratives

Stride Property Group (NZSE:SPG) has just reported H1 2026 results, with revenue coming in at NZ$136.2 million and basic EPS at NZ$0.081952 for the trailing twelve months. Historically, the company saw revenue rise from NZ$53.4 million in H2 2024 to NZ$76.1 million in H2 2025. EPS moved from -NZ$0.010129 to NZ$0.005711 over that span. Margins held steady, giving investors a clear snapshot into the REIT's operational results. See our full analysis for Stride Property Group. Now it’s time to...
NZSE:GMT
NZSE:GMTIndustrial REITs

The Bull Case For Goodman Property Trust (NZSE:GMT) Could Change Following Strong H1 Earnings and Guidance Reaffirmation

Goodman Property Trust has reported its half-year earnings for the period ended September 30, 2025, with sales increasing to NZ$144.5 million and net income rising to NZ$61.8 million compared to the previous year. The trust highlighted strong growth in earnings per unit and maintained its full-year cash earnings guidance, emphasizing resilience despite economic challenges. We’ll explore how Goodman’s reaffirmation of cash earnings guidance may influence the company’s investment narrative...
NZSE:MFT
NZSE:MFTLogistics

Does Mainfreight's (NZSE:MFT) Margin Pressure Hint at a Shift in Its Growth Strategy?

Mainfreight Limited recently released its half-year results, reporting sales of NZ$2.61 billion and net income of NZ$93.38 million, down from the prior year, along with an interim dividend of 85 cents per share approved by the board. The results highlight that while Mainfreight achieved increased revenue, profitability was pressured, indicating the company faced higher costs or margin challenges during the period. We’ll look at how Mainfreight’s earnings growth challenge may shape its...